Baidu
map

国家食药监总局:促进监管科技成果转化 鼓励成果拥有者创业

2017-08-30 佚名 中国医药报

为落实创新驱动发展战略,提高食品药品监管系统科技成果转化能力,加快科技成果向监管技术手段和方法等现实生产力转化,8月25日,国家食品药品监管总局发布《总局关于促进科技成果转化的意见》(以下简称《意见》)。《意见》针对科技成果的范围和内容、健全科技成果转化工作体系、依法依规开展科技成果转化、建立科技成果转化收益分配和激励机制、鼓励拥有科技成果的人员创业等8个方面提出了33条意见。《意见》所称科技成果

为落实创新驱动发展战略,提高食品药品监管系统科技成果转化能力,加快科技成果向监管技术手段和方法等现实生产力转化,8月25日,国家食品药品监管总局发布《总局关于促进科技成果转化的意见》(以下简称《意见》)。《意见》针对科技成果的范围和内容、健全科技成果转化工作体系、依法依规开展科技成果转化、建立科技成果转化收益分配和激励机制、鼓励拥有科技成果的人员创业等8个方面提出了33条意见。

《意见》所称科技成果,是指食药监管系统内具有独立法人资格的技术支撑机构(包括从事检验检测、标准、审评、审核查验、监测、评价、信息等方面工作的单位)、高等院校、企业法人和研究开发机构等单位,通过科学研究与技术开发所产生的具有实用价值的成果,包括能够产生经济效益的科技成果,以及未能产生经济效益或者未能直接产生经济效益,但能够产生较大社会效益的公益性科技成果,如标准、规范、补充检验方法、技术方案和研究方法等。

《意见》明确,总局科技主管部门是食药监管系统内科技成果转化工作的组织部门。各省级食药监管部门以及总局有关直属单位,应加强对科技成果转化的管理、组织和协调,制定相关制度,采取激励措施支持科技成果转化。食药监管系统内科技成果完成单位应当建立和完善科技成果转化管理制度,明确科技成果转化各项工作的责任主体,建立健全科技成果转化重大事项领导班子集体决策制度,加强专业化科技成果转化队伍建设,健全科技成果转化流程,依法完成科技成果转化的具体工作。

《意见》要求,依法依规开展科技成果转化。科技成果完成单位对其持有的科技成果,可以自主决定采取转让、许可或者作价投资等国家法律法规规定的方式进行转化,除涉及国家秘密、国家安全外,不需审批或者备案。

对于科技成果转化收益分配和激励机制,《意见》提出,科技成果完成单位转化科技成果所获得的收入全部留归单位,纳入单位预算,不上缴国库,扣除对完成和转化科技成果作出重要贡献人员的奖励和报酬后,应当主要用于科学技术研发与成果转化等相关工作,并对科技成果完成单位的运行和发展给予保障。科技成果完成单位应规定或者与科技人员约定奖励和报酬的方式、数额和时限。

《意见》同时明确,鼓励拥有科技成果的人员创业,加强科技成果转化绩效评价及示范引导,建立科技成果转化登记及年度报告制度,加强科技成果转化监督管理。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-01 wwzzly
  6. [GetPortalCommentsPageByObjectIdResponse(id=2076227, encodeId=cec920e6227db, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jun 21 15:35:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689882, encodeId=b25e1689882dc, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Tue Mar 13 18:35:00 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705873, encodeId=1ac11e058733a, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Nov 13 20:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840424, encodeId=2a581840424c3, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jan 18 06:35:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1371479, encodeId=dd5813e147968, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513805, encodeId=263c15138053c, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Sep 01 02:35:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]

相关资讯

食药监总局:中成药命名新规不涉及云南白药、同仁堂等老字号

食药监总局就中成药命名新规表示,该规定不涉及承载中医药传统文化的药品名称,如云南白药、同仁堂等来自经典古方的药品不在改名之列。

药监总局扑向药店诊所,卖药的13个雷区别碰!

6月28日,国家食药监总局发布《关于开展城乡接合部和农村地区药店诊所药品质量安全集中整治的通知》。此次整治的重点范围是城乡接合部和农村地区药店、诊所。从现在开始,第三终端迎来最严整顿,一直到年底!自查、省局查、总局查层层推进,不留死角。

进口新药开“绿色通道”,临床通过可优先在国内上市

尽管在药品审评审批体制机制上已经持续改革,但食药监这次放出的“大招”还是让业界有些诧异。日前,食药监总局发布进口药品注册管理有关决定,拟准许境外未注册或尚未进入临床实验的药品可在国内进行国际多中心临床实验,已经在国内完成临床实验之后,可直接提出药品上市注册申请。

食药监总局警告:这种药致畸!孕妇禁用

11月21日,食药监局发布《关于修订维胺酯口服制剂说明书的公告》,决定对维胺酯口服制剂(包括胶囊、软胶囊)说明书增加黑框警告!公告指出,根据药品不良反应评估结果,为进一步保障公众用药安全,国家食品药品监督管理总局决定对维胺酯口服制剂(包括胶囊、软胶囊)说明书增加黑框警告,并对【注意事项】、【不良反应】项进行修订。现将有关事项公告如下:一、所有维胺酯口服制剂生产企业均应依据《药品注册管理办法》等有关

食药监总局:加入ICH可提升制药产业创新能力和国际竞争力

食药监总局举行国际人用药品注册技术协调会(ICH)新闻通气会。国家食药监总局国际合作司司长袁林表示,总局加入ICH体现出国际社会对中国政府药品审评审批制度改革的支持和信心。同时,也意味着中国的药品监管部门、制药行业和研发机构将逐步转化和实施国际最高技术标准和指南,可以有效提升国内制药产业创新能力和国际竞争力。资料显示,5月31日至6月1日,ICH2017年第一次会议正式批准国家食药监总局成为其成员

食药监总局:20批次药品不合格,含抢救药盐酸洛贝林注射液

国家食品药品监督管理总局日前发布通告称,标示为华润双鹤药业股份有限公司等4家企业生产的盐酸洛贝林注射液等20批次药品不合格。相关企业已被要求暂停销售使用、召回产品,并进行整改。根据通告,不合格药品情况为:华润双鹤药业股份有限公司生产的16个批次盐酸洛贝林注射液,临江市宏大药业有限公司生产的批号为160101、160802的根痛平胶囊,长春万德制药有限公司生产的批号为20160501的根痛平胶囊,吉

Baidu
map
Baidu
map
Baidu
map